Mark Danese

Summary

Publications

  1. pmc Effect of central nervous system metastases on treatment discontinuation and survival in older women receiving trastuzumab for metastatic breast cancer
    Mark D Danese
    Outcomes Insights, Inc, Outcomes Research, Westlake Village, CA 91632, USA
    J Cancer Epidemiol 2012:819210. 2012
  2. pmc Health care utilization and mortality among elderly patients with myelodysplastic syndromes
    K J Lindquist
    Outcomes Insights, Inc, Westlake Village, CA, USA
    Ann Oncol 22:1181-8. 2011
  3. pmc Misclassification of incident conditions using claims data: impact of varying the period used to exclude pre-existing disease
    Robert I Griffiths
    Outcomes Insights, Inc, 340 North Westlake Blvd, Suite 200, Westlake Village, CA 91362, USA
    BMC Med Res Methodol 13:32. 2013
  4. pmc Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare
    Robert I Griffiths
    Department of Epidemiology, Outcomes Insights, Inc, 340 N Westlake Blvd, Suite 200, Westlake Village, CA 91362, USA
    BMC Cancer 12:613. 2012
  5. pmc An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancer
    M D Danese
    Epidemiology and Outcomes Research, Outcomes Insights Inc, Westlake Village, USA
    Ann Oncol 23:1756-65. 2012
  6. pmc An observational study of outcomes after initial infused therapy in Medicare patients diagnosed with chronic lymphocytic leukemia
    Mark D Danese
    Outcomes Insights Inc, 340 N Westlake Blvd, Westlake Village, CA 91362, USA
    Blood 117:3505-13. 2011
  7. doi Estimating recurrences prevented from using trastuzumab in HER-2/neu-positive adjuvant breast cancer in the United States
    Mark D Danese
    Outcomes Insights, Inc, Newbury Park, California, USA
    Cancer 116:5575-83. 2010
  8. doi Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura
    Mark D Danese
    Outcomes Insights, Inc, Newbury Park, California, USA
    Am J Hematol 84:631-5. 2009
  9. doi Effect of adherence on lifetime fractures in osteoporotic women treated with daily and weekly bisphosphonates
    Mark D Danese
    Outcomes Insights, Westlake Village, California, USA
    J Bone Miner Res 24:1819-26. 2009
  10. pmc Consistent control of mineral and bone disorder in incident hemodialysis patients
    Mark D Danese
    Outcomes Insights, Inc, Newbury Park, California, USA
    Clin J Am Soc Nephrol 3:1423-9. 2008

Collaborators

Detail Information

Publications14

  1. pmc Effect of central nervous system metastases on treatment discontinuation and survival in older women receiving trastuzumab for metastatic breast cancer
    Mark D Danese
    Outcomes Insights, Inc, Outcomes Research, Westlake Village, CA 91632, USA
    J Cancer Epidemiol 2012:819210. 2012
    ..1 per 1,000). Conclusion. The diagnosis of CNS metastases was associated with an increase in both the likelihood of discontinuing trastuzumab therapy as well as the risk of death...
  2. pmc Health care utilization and mortality among elderly patients with myelodysplastic syndromes
    K J Lindquist
    Outcomes Insights, Inc, Westlake Village, CA, USA
    Ann Oncol 22:1181-8. 2011
    ..The relationships between these events and the MDS complications of anemia, neutropenia, and thrombocytopenia are not well understood...
  3. pmc Misclassification of incident conditions using claims data: impact of varying the period used to exclude pre-existing disease
    Robert I Griffiths
    Outcomes Insights, Inc, 340 North Westlake Blvd, Suite 200, Westlake Village, CA 91362, USA
    BMC Med Res Methodol 13:32. 2013
    ..Using Medicare claims, we examined the impact of selecting shorter versus longer prevalence periods on the incidence and misclassification of 12 relatively common conditions in older persons...
  4. pmc Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare
    Robert I Griffiths
    Department of Epidemiology, Outcomes Insights, Inc, 340 N Westlake Blvd, Suite 200, Westlake Village, CA 91362, USA
    BMC Cancer 12:613. 2012
    ..Our objectives were to identify factors associated with previously undiagnosed diabetes in breast cancer, and to examine associations between previously undiagnosed diabetes and cancer stage, treatment patterns, and mortality...
  5. pmc An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancer
    M D Danese
    Epidemiology and Outcomes Research, Outcomes Insights Inc, Westlake Village, USA
    Ann Oncol 23:1756-65. 2012
    ..Longitudinal analyses of comorbid conditions in women with breast cancer are few...
  6. pmc An observational study of outcomes after initial infused therapy in Medicare patients diagnosed with chronic lymphocytic leukemia
    Mark D Danese
    Outcomes Insights Inc, 340 N Westlake Blvd, Westlake Village, CA 91362, USA
    Blood 117:3505-13. 2011
    ..These analyses, based on observational data, suggest that the benefits of initial therapy with rituximab in a heterogeneous group of older CLL patients are comparable with those demonstrated in younger patients...
  7. doi Estimating recurrences prevented from using trastuzumab in HER-2/neu-positive adjuvant breast cancer in the United States
    Mark D Danese
    Outcomes Insights, Inc, Newbury Park, California, USA
    Cancer 116:5575-83. 2010
    ..Patients with early stage HER2+ tumors are at increased risk of recurrence. The use of trastuzumab for these patients has been shown to reduce recurrences and improve overall survival...
  8. doi Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura
    Mark D Danese
    Outcomes Insights, Inc, Newbury Park, California, USA
    Am J Hematol 84:631-5. 2009
    ..ITP was associated with higher costs, longer stays, and more in-hospital deaths on average than all other hospitalized patients combined...
  9. doi Effect of adherence on lifetime fractures in osteoporotic women treated with daily and weekly bisphosphonates
    Mark D Danese
    Outcomes Insights, Westlake Village, California, USA
    J Bone Miner Res 24:1819-26. 2009
    ..These results show that there is implicit value to improving adherence, both from a financial and clinical perspective...
  10. pmc Consistent control of mineral and bone disorder in incident hemodialysis patients
    Mark D Danese
    Outcomes Insights, Inc, Newbury Park, California, USA
    Clin J Am Soc Nephrol 3:1423-9. 2008
    ..In 2003, the National Kidney Foundation introduced guidelines for the control of parathyroid hormone, calcium, and phosphorus in hemodialysis patients...
  11. ncbi Budget impact model of adding erlotinib to a regimen of gemcitabine for the treatment of locally advanced, nonresectable or metastatic pancreatic cancer
    Mark D Danese
    Outcomes Insights, Inc, Newbury Park, California 91320, USA
    Clin Ther 30:775-84. 2008
    ..The aim of this study was to determine the budget impact of adding erlotinib to a US health plan insurer's formulary as a combination therapy with gemcitabine for the treatment of nonresectable pancreatic cancer...
  12. pmc Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma
    Robert Griffiths
    Outcomes Insights Inc, Westlake Village, CA, USA
    Blood 118:4808-16. 2011
    ..We conclude that first-line chemotherapy including rituximab is associated with significantly improved survival in older patients diagnosed with MCL...
  13. doi A novel approach to the evaluation of bleeding-related episodes in patients with chronic immune thrombocytopenia
    Ilene Weitz
    University of Southern California Keck School of Medicine, Los Angeles, CA, USA
    Curr Med Res Opin 28:789-96. 2012
    ..This study evaluated a new and possibly more accurate way of assessing the effects of a treatment intervention on bleeding-related outcomes. We developed a composite endpoint, termed bleeding-related episodes (BRE)...
  14. pmc Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
    Robert Griffiths
    Outcomes Insights, Inc, Westlake Village, CA, USA
    BMC Cancer 10:625. 2010
    ..Although it is an aggressive type of lymphoma, 40% to 50% of patients are cured with treatment. The study objectives were to identify patient factors associated with treatment and survival in DLBCL...